Novo Nordisk | NVO - Operating Profit

Stock Price
37.61
Daily Change
0.70 1.90%
Monthly
-5.43%
Yearly
-42.25%
Q2 Forecast
35.05

Novo Nordisk reported DKK5.18B in Operating Profit for its fiscal quarter ending in June of 2025.





Operating Profit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Bausch Health Companies USD 719M 2M Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Drreddys Laboratories INR 14.33B 2.51B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 33.61B Jun/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Zoetis USD 835M 101M Dec/2025